← Back to Home

Smart Rings Cross the Medical Device Threshold: Galaxy Ring to Screen for Sleep Apnea Risk

Samsung says it will bring an FDA-cleared risk-detection feature to the existing Galaxy Ring this fall; the ring could reduce the burden of long-term overnight monitoring, but cannot replace sleep testing or a physician’s diagnosis.

By SURL BioNews

Sleep apnea often occurs at night without the person realizing it. From snoring and repeated oxygen deprivation to daytime fatigue, it may go unrecognized for years. Samsung is now attempting to put initial screening into an everyday wearable ring: the company announced that the existing Galaxy Ring is expected to add an over-the-counter sleep apnea risk-detection feature in fall 2026.

Sharanya Desai, Samsung’s head of digital health, said at the Galaxy Unpacked event in London that the feature will make the Galaxy Ring the first and currently only over-the-counter ring device cleared by the U.S. Food and Drug Administration for sleep apnea risk detection. Multiple technology media outlets reported the same timeline and positioning, but Samsung has not yet released the complete clearance documents, conditions of use, or performance data for the ring version.

The feature’s primary purpose is not to make a diagnosis, but to look for signs of repeated breathing obstruction in physiological signals collected during sleep and then use an algorithm to determine whether the user may be at risk. The Galaxy Ring can already track heart rate, blood oxygen, skin temperature, and sleep activity; Samsung says the new feature will combine sensor data with artificial intelligence algorithms to further analyze nighttime breathing interruptions.

The ring’s potential advantage is its lower burden. Compared with sleep testing performed at a medical facility with multiple connected sensors, a device worn over the long term can more easily accumulate data across multiple nights and may alert people who otherwise would not proactively seek medical care. However, consumer wearables can provide screening clues, not distinguish obstructive from central sleep apnea, determine severity, or establish a treatment plan.

Smart-ring products already on the market can display changes in blood oxygen, breathing disturbances, or related alerts, but reports indicate that these features do not have FDA clearance for an equivalent intended use. Regulatory recognition is therefore more than a marketing label: it defines the medical uses the software may claim and requires the manufacturer to support its safety and performance with corresponding evidence. However, the publicly available information remains insufficient to determine how the ring’s algorithm was validated, which populations it was tested in, or the rates of false positives and false negatives.

Samsung said compatible Galaxy Watch models will receive a new sleep apnea monitoring feature first in summer 2026, with the Galaxy Ring following in the fall. For users, a risk alert must still be followed up and confirmed by a healthcare professional; the absence of an alert also cannot rule out the condition. The ring’s true clinical value will depend on its scope of use and validation data after the official launch, as well as whether it can effectively connect digital alerts with diagnosis and treatment.

References

  1. Android Central
  2. Tom's Guide
  3. Android Authority